PDGF-D expression is down-regulated by TGFβ in fibroblasts

Area of Science:

• Cell Biology
• Molecular Biology
• Fibrosis Research

Background:

• Transforming growth factor-β (TGFβ) is a critical mediator of fibrogenesis, promoting fibroblast differentiation and extracellular matrix deposition.
• Platelet-derived growth factor (PDGF) also regulates fibrogenesis, with prior studies suggesting links to TGFβ in certain fibrotic conditions.
• PDGF-C and PDGF-D are recently identified PDGF ligands implicated in fibrotic processes.

Purpose of the Study:

• To investigate the relationship between TGFβ and the novel PDGF-C and PDGF-D ligands.
• To elucidate the molecular mechanisms underlying TGFβ-mediated regulation of PDGF-C and PDGF-D.
• To explore the role of this interaction in a preclinical model of lung fibrosis.

Main Methods:

• Analysis of PDGF-C and PDGF-D mRNA and protein expression in normal fibroblasts treated with TGFβ.
• Assessment of TGFβ-induced changes using various kinase inhibitors, including TGFβ receptor inhibitors and an IκB kinase (IKK) inhibitor (BMS-345541).
• Evaluation of PDGF-D expression in a bleomycin- and silica-induced lung fibrosis model.

Main Results:

• TGFβ significantly down-regulated PDGF-D expression and up-regulated PDGF-C expression at both mRNA and protein levels in normal fibroblasts.
• Other fibrotic growth factors, including FGF, EGF, and PDGF-B, also modulated PDGF-C and PDGF-D expression.
• TGFβ receptor inhibitors and the IKK inhibitor BMS-345541 blocked TGFβ's effects, though classical NF-κB pathway activation was not implicated.
• In lung fibrosis models, PDGF-D was down-regulated, correlating with elevated TGFβ and other fibrotic growth factors.

Conclusions:

• TGFβ exerts differential regulation on PDGF-C and PDGF-D, representing a novel interaction in fibrotic pathways.
• The down-regulation of PDGF-D by TGFβ and other growth factors may function as a negative feedback mechanism within the cytokine network controlling fibrosis.
• These findings offer new insights into the complex molecular interplay governing fibrotic diseases.